Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-094-6 | CAS number: 7786-30-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 2003
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Reliability 2 is applied because the original report is not available. But the study was perfomed according to the OECD 421 and this study was peer reviewed (SIDS, OECD HPV program). This study is available in the SIDS of magnesium chloride (SIDS Initial Assessment Report For SIAM 32, 18-21 April 2011, Paris, France)
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Reference Type:
- publication
- Title:
- SIDS Dossier , OECD HPV Chemical Programme, SIDS Dossier approved at SIAM 32 (19-21 April 2011)
- Author:
- OECD HPV Chemical Programme
- Year:
- 2 011
- Bibliographic source:
- SIDS Dossier and SIDS Initial Assessment Report For SIAM 32
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- Magnesium chloride
- EC Number:
- 232-094-6
- EC Name:
- Magnesium chloride
- Cas Number:
- 7786-30-3
- Molecular formula:
- Cl2Mg
- IUPAC Name:
- magnesium dichloride
- Details on test material:
- - Analytical purity: reagent grade
Constituent 1
- Specific details on test material used for the study:
- Molecular formular: MgCl2
- Supplier:Sigma-Aldrich, Inc.
- Lot No.: 052K0893
- Purity: 98.0%
- Description: White powder
- Storage condition: Room temperature
Test animals
- Species:
- mouse
- Strain:
- ICR
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- [Test animals]
- Source: Samtako Bio Korea Inc.
- Age at study initiation: 8 weeks
- Weight at study initiation: 33.9 to 37.5 grams
- Fasting period before study: Not reported
- Housing: Metallic cage
- Diet (e.g. ad libitum): ad libitum (Purina experimental diet for rats 5057 (Agri Brands Prina Korea, Inc.))
- Water (e.g. ad libitum): ad libitum (Filtered and sterilized drinking water)
[Environmental conditions]
- Temperature (°C): 20 to 25 °C
- Humidity (%): 50 +/-10 %
- Air changes (per hr): 10 to 15 per hours
- Photoperiod (hrs dark / hrs light): 12 / 12 hours
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Chemical name: Distilled water
- CAS No.: Not reported
- Lot No.: Not reported
- Storage condition: Room temperature - Duration of treatment / exposure:
- 24 hours
- Frequency of treatment:
- two times per 24 hours
Doses / concentrationsopen allclose all
- Dose / conc.:
- 120 mg/kg bw/day (nominal)
- Dose / conc.:
- 60 mg/kg bw/day (nominal)
- Dose / conc.:
- 30 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 6/male/dose
- Control animals:
- yes
- Positive control(s):
- - Chemical name: Mitomycin C (MMC)
- CAS No.: Not reported
- Supplier: Sigma-Aldrich Korea.
- Lot No.: 111K2511
Examinations
- Tissues and cell types examined:
- Eahc specimen was observed by microscope with a magnification of 1,000. To calculate the proportion of PCE in the total erythrocytes [PCE/(PCE+NCE)], sum of polychromatic eryhrocyte (PCE) and normochromatic erythrocyte (NCE) should be 1,000 and to calculate the proportion of MNPCE in the micronucleated polychromatic erythrocyte [MNPCE/(1,000 PCE)], polychromatic erythrocyte (PCE) were counted 2,000.
- Details of tissue and slide preparation:
- Bone marrow cells collection was carried out at the time decided in the induction of micronucleus, 24 hours. To collect the bone marrow cells, mice were euthanized by dislocation of cervical vertebrae, after that the 200 uL of fetal bovine serum (Hyclone, USA) was run through an extracted femur using a 1.0 mL disposable syringe with a needle. Finally, collected samples were centrifuged at 1,000 rpm, 4℃, for 5 miniutes. The supernatant was discarded and the cell pellet was mixed well and then smeared on the slide glass. Two specimens per animal were produced, in which they were air-dried and stained with a 5% Giemsa solution for 30 minutes and observed at 1,000 fold magnification under the microscope.
- Evaluation criteria:
- It was judged as a positive when MNPCE was increased significantly in dose dependent manner or there was reproducible increase in number of MNPCE at least one test level.
- Statistics:
- In accordance with the table of Kastenbaum and Bowman, statistical significance was tested for the induction frequency of micronucleus and the t-test was conducted for an appearance rate for polychromatic erytrocyte (PCE) in 5% significant levels in p-value statistically. We conducted the ANOVA test for a body weight change within 5% significant levels in p-value statistically.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- [Clinical signs and mortality]
- There were no treatment related mortality and clinical signs for all groups. No dead animals were founded in all groups.[Measurement of body weight (Table 2)]
- There was no significant body weight change for the all test groups during the the test period.[In vivo micronucleus test (Table 3)]
- The micronucleated polychromatic erythrocytes (MNPCE) were not increased all the time in the preliminary test to establish a bone marrow cells collection times. Therefore, collection time was decided at 24 hours after the treatment. The frequency of micronucleated polychromatic erythrocytes (MNPCE) induction per 1,000 polychromatic erythrocytes (PCE) was 0.8, 0.4, 0.8 and 1.1 for the negative control, 30, 60 and 120 mg/kg of treatment groups, respectively. Therefore, there was no significant difference in appearance rate of micronicleated polychromatic erythrocytes (MNPCE) in polychromatic erythrocytes (PCE) for all treatment groups in contrast with that of the negative control. In the positive control, the frequency of micronucleated MNPCE induction per 1,000 PCE was 79.0 and micronucleated PCE was significantly increased in contrast with that of the negative control. The PCE/(PCE+NCE) ratio, criterion of cytotoxicity, following dose levels 0 (negative control), 30, 60 and 120 mg/kg and positive control (MMC) were 0.499, 0.503, 0.499, 0.499 and 0.496, respectively. There was no significant difference between the treatment groups and control group.
Any other information on results incl. tables
Table 2. Change of body weight
Hours after treatment | Groups | G1 | G2 | G3 | G4 | G5 |
0 | Dose (mg/kg) | 0 (NC) | 30 | 60 | 120 | 2.0 (PC) |
Mean | 36 | 36.2 | 36 | 36 | 36 | |
SD | 1.5 | 1.3 | 1.3 | 1.0 | 1.0 | |
N | 6 | 6 | 6 | 6 | 6 | |
24 | Mean | 35.2 | 34.9 | 35.1 | 34.3 | 35.2 |
SD | 1.3 | 1.7 | 1.2 | 1.8 | 1.6 | |
N | 6 | 6 | 6 | 6 | 6 |
Table 3. Micronucleus test of magnesium chloride (CAS No.: 7786 -30 -3) in male ICR mice
Groups | Test substance | Dose (mg/kg) | N | Sampling time (Hr) | MNPCE/1,000 PCE (Mean+/-SD) | PCE/(PCE+NCE) (Mean +/- SD) |
G1 | Distilled water | 0 | 6 | 24 | 0.8 +/- 0.5 | 0.499 +/- 0.005 |
G2 | Magnesium chloride | 30 | 6 | 24 | 0.4 +/- 0.5 | 0.503 +/- 0.005 |
G3 | 60 | 6 | 24 | 0.8 +/- 0.6 | 0.499 +/- 0.008 | |
G4 | 120 | 6 | 24 | 1.1 +/- 0.4 | 0.499 +/- 0.008 | |
G5 | Mitomycin C | 2 | 6 | 24 | 79.0* +/-5.4 | 0.496 +/- 0.004 |
*: Indicate significan difference at p<0.01 level
Applicant's summary and conclusion
- Conclusions:
- In conclusion, the test substance, magnesium chloride did not influence on the micronucleus formation in the bone marrow cells in mice.
- Executive summary:
This study was designed to determine the mutagenic potential of magnesium chloride in the micronucleus test using bone marrow cells in ICR mice. The serial doses of the test substance such as 30, 60 and 120 mg/kg were administrated by intraperitoneally (i.p).10 mL/kg of distilled water was also administrated by i.p to negative control group and 2.0 mg/kg of mitomycin C. In 24 hours after the treatment, all mice were sacrificed then bone marrow cells in thigh were collected. The specimens were stained with 5% Giemsa solution. The frequency of micronucleus induction was observed by a microscope. As a result, there was no significant difference in appearance rate (MNPCE/1,000 PCE) of micronucleated polychromatic erythrocytes (MNPCE) in polychromatic erythrocytes (PCE) for all treatment groups in contrast with that of the negative control. However, in the positive control group, an appearance rate of MNPCE was increased significantly in contrast with that of the negative control. The PCE/(PCE+NCE) ratio for all treatment groups was not different significantly in contrast with that of the negative control. In conclusion, the test substance, magnesium chloride did not influence on the micronucleus formation in the bone marrow cells in mice
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.